Lista de obras -

Absence of Peripheral Pulses and Risk of Major Vascular Outcomes in Patients With Type 2 Diabetes

artículo científico publicado en 2016

Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes

artículo científico publicado en 2009

Blood pressure variables and cardiovascular risk: new findings from ADVANCE.

artículo científico publicado en 2009

Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial

artículo científico publicado en 2017

Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ON.

artículo científico publicado en 2017

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial

artículo científico publicado en 2009

Comparison of waist-to-hip ratio and other obesity indices as predictors of cardiovascular disease risk in people with type-2 diabetes: a prospective cohort study from ADVANCE.

artículo científico publicado en 2011

Contemporary model for cardiovascular risk prediction in people with type 2 diabetes

artículo científico publicado en 2011

Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease

artículo científico publicado en 2010

Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial

artículo científico publicado en 2013

Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial

artículo científico publicado en 2013

Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence.

artículo científico publicado en 2008

Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial

artículo científico publicado en 2010

Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial.

artículo científico publicado en 2010

Follow-up of blood-pressure lowering and glucose control in type 2 diabetes

artículo científico publicado en 2014

Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON.

artículo científico publicado en 2016

Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy: results of the ADVANCE study

artículo científico publicado en 2012

Lowering blood pressure reduces renal events in type 2 diabetes

artículo científico publicado en 2009

Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes.

artículo científico publicado en 2016

Prediction of 10-year vascular risk in patients with diabetes: the AD-ON risk score

artículo científico publicado en 2015

Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study

artículo científico publicado en 2016

Prognostic Value of Variability in Systolic Blood Pressure Related to Vascular Events and Premature Death in Type 2 Diabetes Mellitus: The ADVANCE-ON Study

artículo científico publicado en 2017

Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes.

artículo científico publicado en 2015

Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study

artículo científico publicado en 2009

Severe hypoglycemia and risks of vascular events and death

artículo científico publicado en 2010

The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Pr

artículo científico publicado en 2010

Lista de obras de

Absence of Peripheral Pulses and Risk of Major Vascular Outcomes in Patients With Type 2 Diabetes

Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes

Blood pressure variables and cardiovascular risk: new findings from ADVANCE.

Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial

Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ON.

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial

Comparison of waist-to-hip ratio and other obesity indices as predictors of cardiovascular disease risk in people with type-2 diabetes: a prospective cohort study from ADVANCE.

Contemporary model for cardiovascular risk prediction in people with type 2 diabetes

Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease

Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial

Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial

Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence.

Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial

Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial.

Follow-up of blood-pressure lowering and glucose control in type 2 diabetes

Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON.

Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy: results of the ADVANCE study

Lowering blood pressure reduces renal events in type 2 diabetes

Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes.

Prediction of 10-year vascular risk in patients with diabetes: the AD-ON risk score

Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study

Prognostic Value of Variability in Systolic Blood Pressure Related to Vascular Events and Premature Death in Type 2 Diabetes Mellitus: The ADVANCE-ON Study

Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes.

Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study

Severe hypoglycemia and risks of vascular events and death

The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Pr